Fibrose Pulmonar Online (Pulmonary fibrosis)
■ The diagnosis of idiopathic pulmonary fibrosis: current and future approaches
Fernando J Martinez, Alison Chisholm, Harold R Collard et al
Lancet Respir Med. 2017, vol 5(1): 61–71
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524148/
■ Idiopathic pulmonary fibrosis in Switzerlands: diagnosis and treatment
Position paper of the Swiss Working Group for Interstitial and Rare Lung Diseases of the Swiss Respiratory Society
M Funke-Chambour, A Azzola, D Adler et al
Respiration 2017, vol 93: 363-378
https://www.karger.com/Article/Fulltext/464332
■ Oxigenoterapia de alto fluxo nasal em pacientes com fibrose pulmonary idiopática sob cuidados paliativos: relato de um caso
F S L Silva, P H Barreto, R S de Vasconcelos et al
Rev Med UFC 2017, vol 57 (1): 69-72
http://www.revistademedicina.ufc.br/ojs/index.php/revistademedicinaufc/article/view/174/135
■ Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
Elisabeth Dowling Root, Bridget Graney, Susan Baird et al
BMC Pulm Med. 2017; vol 17: 154
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701349/
■ Recents advances in managing idiopathic pulmonary fibrosis
C Scelfo, A Caminati, S Harari
Version 1, F1000Res 2017, vol 6: 2052
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710314/
■ Fibrose pulmonar idiopática no Brasil: desafios para caracterização epidemiológica e abordagem
B G Baldi
- bras. pneumol., Dec 2017, vol.43, no.6
■ Mortalidade por fibrose pulmonar idiopática: análise temporal no Brasil, 1979-2014
Algranti, Eduardo et al
- bras. pneumol., Dec 2017, vol.43, no.6, p.445-450
■ Caracterización clínica, serológica y patrón radiológico de una cohorte unicéntrica de pacientes con enfermedad pulmonar difusa
Chahuán S, José Miguel et al
Rev. chil. enferm. respir., Mar 2017, vol.33, no.1, p.31-36.
https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-73482017000100005&lng=es&nrm=iso
■ Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
L H Lancaster, J A de Andrade, J D Zibrak et al
European Respiratory Review 26 (146): 170057
http://err.ersjournals.com/content/26/146/170057
■ Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
G Raghu
European Respiratory Review 26 (145): 170071
http://err.ersjournals.com/content/26/145/170071
■ Severe idiopathic pulmonary fibrosis: What can be done?
A Camininati, R Cassandro, Olga Torre, S Harari
European Respiratory Review 26 (145): 170004
http://err.ersjournals.com/content/26/145/170047
■ When to start and when to stop antifibrotic therapies
S E Torrisi, M Pavone, A Vancheri, C Vancheri
European Respiratory Review 26 (145): 170053
http://err.ersjournals.com/content/26/145/170053
■ Recent lessons learned in the management of acute exacerbations of idiopathic pulmonary fibrosis
Y Kondoh, V Cottin, K K Brown
European Respiratory Review 26 (145): 170050
http://err.ersjournals.com/content/26/145/170050
■ Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines
R Sharif
AJMC july 2017
■ Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis
Amy L. Olson, Bridget Graney, Susan Baird et al
BMC Pulm Med. 2017; 17: 152
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700736/
■ Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways
Christopher M. Evans, Tasha E. Fingerlin et al
Physiol Rev. 2016 Oct; 96(4): 1567–159
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243224/
■ Comorbid conditions in idiopathic pulmonary fibrosis: recognition and management
Justin M. Oldham, Harold R. Collard
Front Med (Lausanne) 2017; vol 4: 12
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539138/
■ Role of microbial agents in pulmonary fibrosis
Ozioma S. Chioma, Wonder P. Drake
Yale J Biol Med. 2017, vol 90(2): 219–227
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482299/
■ Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
Bridget A. Graney, Frederick S. Wamboldt, Susan Baird et al
Health Qual Life Outcomes. 2017; vol 15: 133
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494136/
■ Pulmonary hypertension associated with idiopathic pulmonary fibrosis: current and future perspectives
Scott D. Collum, Javier Amione-Guerra, Ana S. Cruz-Solbes et al
Can Respir J. 2017; 2017: 1430350
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327768/
■ The processes and mechanisms of cardiac and pulmonary fibrosis
Lucy A. Murtha, Michael J. Schuliga, Nishani S. Mabotuwana et al
Front Physiol. 2017; vol 8: 777
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643461/
■ Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
Richard J Allen, Joanne Porte, Rebecca Braybrooke et al
Lancet Respir Med. 2017, vol 5(11): 869–880
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666208/
■ Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis and treatment
Amarpreet Kaur, Susan K. Mathai, David A. Schwartz
Front Med (Lausanne) 2017; vol 4: 154
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622313/
■ Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT
Lisa P. Lavelle, Darragh Brady, Sinead McEvoy et al
Diagn Interv Radiol. 2017 , vol 23(2): 106–111
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338575/
■ Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patiens with idiopathic pulmonary fibrosis
Milica Vukmirovic, Jose D. Herazo-Maya, John Blackmon et al
BMC Pulm Med. 2017; 17: 15
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228096/
■ Pulmonary oxygen uptake and muscle deoxygenation kinetics during heavy intensity cycling exercise in patiens with emphysema and idiopathic pulmonary fibrosis
Melitta A. McNarry, Nicholas K. Harrison, Tom Withers et al
BMC Pulm Med. 2017; 17: 26.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282850/
■ Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden
Joshua J. Mooney, Karina Raimundo, Eunice Chang, Michael S. Broder
BMC Pulm Med. 2017; 17: 84
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441011/
■ Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study
Kodai Kawamura, Kazuya Ichikado, Yuko Yasuda et al
BMC Pulm Med. 2017; 17: 94.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477160/
■ Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis
Thomas Bahmer, Anne-Marie Kirsten, Benjamin Waschki et al
BMC Pulm Med. 2017; vol 17: 104
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526311/
■ Unmet needs in the treatment of idiopathic pulmonary fibrosis – insights from patient chart review in five European countries
Toby M. Maher, Maria Molina-Molina, Anne-Marie Russell et al
BMC Pulm Med. 2017; 17: 124.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602932/
■ Hipertensión pulmonar en pacientes con fibrosis pulmonar y sobrevida post-trasplante pulmonar
Briceño V, Catalina et al
Rev. chil. enferm. respir., Mar 2016, vol.32, no.1, p.13-17
https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-73482016000100003&lng=es&nrm=iso
■ Trasplante pulmonar en pacientes portadores de fibrosis pulmonar: caracterización de una cohorte de 87 pacientes
Parada C, María Teresa et al
Rev. chil. enferm. respir., Dic 2015, vol.31, no.4, p.189-194
https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-73482015000400002&lng=es&nrm=iso
■ Pulmonary fibrosis: pathogenesis, etiology and regulation
M S Wilson, T A Wynn
Mucosal Immunol 2009, vol 2 (2): 103-121
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675823/
■ by Dr Paulo Fernando Leite
Cardiologia – Centro Médico Unimed BH
Rua Gonçalves Dias 202
Belo Horizonte/MG/Brasil
31 30033306 / 40204020
CRMMG: 7026
Email: pfleite1873@gmail.com